Since ROS also activates NLRP3 inflammasomes, increased ROS levels promote IL-1β and TGF-β production, leading to the fibrotic effects observed in human CFs. This evidence concerns the gene TGFB1 and myalgic encephalomeyelitis/chronic fatigue syndrome.